Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
Top Cited Papers
Open Access
- 1 September 2009
- journal article
- practice guideline
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 94 (9), 3132-3154
- https://doi.org/10.1210/jc.2009-0345
Abstract
Objective: The aim was to formulate practice guidelines for endocrine treatment oftranssexual persons. Evidence: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and the quality of evidence, which was low or very low. Consensus Process: Committees and members of The Endocrine Society, European Society of Endocrinology, European Society for Paediatric Endocrinology, Lawson Wilkins Pediatric Endocrine Society, and World Professional Association for Transgender Health commented on preliminary drafts of these guidelines. Conclusions: Transsexual persons seeking to develop the physical characteristics of the desired gender require a safe, effective hormone regimen that will 1) suppress endogenous hormone secretion determined by the person’s genetic/biologic sex and 2) maintain sex hormone levels within the normal range for the person’s desired gender. A mental health professional (MHP) must recommend endocrine treatment and participate in ongoing care throughout the endocrine transition and decision for surgical sex reassignment. The endocrinologist must confirm the diagnostic criteria the MHP used to make these recommendations. Because a diagnosis of transsexualism in a prepubertal child cannot be made with certainty, we do not recommend endocrine treatment of prepubertal children. We recommend treating transsexual adolescents (Tanner stage 2) by suppressing puberty with GnRH analogues until age 16 years old, after which cross-sex hormones may be given. We suggest suppressing endogenous sex hormones, maintaining physiologic levels of gender-appropriate sex hormones and monitoring for known risks in adult transsexual persons. Endocrine treatment of transsexual persons should include suppression of endogenous sex hormones, physiologic levels of gender-appropriate sex hormones, and suppression of puberty in adolescents (Tanner stage 2).Keywords
This publication has 99 references indexed in Scilit:
- Prospective Observational Study of Thermablate Endometrial Ablation System as an Outpatient ProcedureJournal of Minimally Invasive Gynecology, 2008
- A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation SystemJournal of Clinical Endocrinology & Metabolism, 2008
- Current management of male-to-female gender identity disorder in the UKHeart, 2007
- Regret after Sex Reassignment Surgery in a Male-to-Female Transsexual: A Long-Term Follow-UpArchives of Sexual Behavior, 2006
- Longitudinal Changes in Insulin Sensitivity, Insulin Secretion, and β-Cell Function During PubertyThe Journal of Pediatrics, 2006
- Testosterone increases bone mineral density in female‐to‐male transsexuals: a case series of 15 subjectsClinical Endocrinology, 2004
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Bone mineral density during treatment of central precocious pubertyThe Journal of Pediatrics, 1995
- Adverse effects of large doses ofmedroxyprogesterone (MPA) in idiopathic isosexual precocityThe Journal of Pediatrics, 1971
- Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics.BMJ, 1968